We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWTG:NASDAQNewton Golf Company, Inc. Analysis

Data as of 2026-06-03 - not real-time

$0.98

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Newton Golf Company (NWTG) is trading well below its 20‑day, 50‑day and 200‑day simple moving averages, indicating a sustained bearish price pressure. RSI sits around the mid‑40s, suggesting the stock is not yet oversold, while the MACD line has just crossed above its signal, producing a modest bullish histogram that may signal a short‑term technical bounce. However, the broader trend remains bearish, with a computed volatility of over 100% in the past 30 days and a beta well above market, underscoring high price swings. The company’s fundamentals are weak: revenue fell 18% YoY in Q1 2026 amid production upgrades, margins are deeply negative, and both operating and free cash flow are strongly negative, leaving a zero ROE and a high price‑to‑book multiple of nearly 5×. No dividend is paid, and the forward PE is negative, reinforcing the view that the stock is currently overvalued relative to its earnings outlook. Recent earnings call material highlighted strategic restructuring but also widened net losses, adding to execution risk. The sector (Consumer Cyclical – Leisure) is sensitive to discretionary spending cycles, further amplifying downside risk in a high‑inflation environment. While the analyst consensus is a “hold” with a median price target of $4.75, the gap between current price (~$1) and that target appears speculative given the company’s cash burn and lack of profitability. Investors should therefore treat NWTG as a high‑risk, potentially overvalued play, with any upside hinging on successful execution of its restructuring plan and a turnaround in cash flow generation.
Given the current technical and fundamental landscape, short‑term traders may consider exiting positions, medium‑term investors might adopt a cautious hold pending clearer operational improvements, and long‑term holders should monitor cash flow trends closely before committing additional capital.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major SMAs
  • High short‑term volatility
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential operational restructuring benefits
  • MACD bullish crossover
  • Continued cash burn risk

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Uncertain path to profitability
  • Elevated price‑to‑book multiple
  • Sector exposure to discretionary spending

Key Metrics & Analysis

Financial Health

Revenue Growth112.40%
Profit Margin-74.00%
P/E Ratio-3.0
ROA-72.22%
Debt/Equity9.07
P/B Ratio4.9
Op. Cash Flow$-5166000
Free Cash Flow$-16590500

Technical Analysis

TrendBearish
RSI41.5
Support$0.85
Resistance$1.25
MA 20$1.05
MA 50$1.23
MA 200$1.53
MACDBullish
VolumeStable
Fear & Greed Index93.27

Valuation

Target Price$4.75
Upside/Downside384.69%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.47
Volatility109.07%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.